Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/31700
Title: Neural correlates of implicit emotion regulation in mood and anxiety disorders: an fMRI meta-analytic review
Authors: Dalton, SDP
Cooper, H
Jennings, B
Cheeta, S
Keywords: implicit emotion regulation;emotion regulation;depression;anxiety;meta-analysis;fMRI
Issue Date: 4-Jun-2025
Publisher: Springer Nature
Citation: Dalton, S.D.P. et al. (2025) 'Neural correlates of implicit emotion regulation in mood and anxiety disorders: an fMRI meta-analytic review', Scientific Reports, 15 (1), 19564, pp. 1 - 17. doi: 10.1038/s41598-025-03828-5.
Abstract: Maladaptive implicit emotion regulation has been highlighted as a transdiagnostic characteristic of mood and anxiety disorders. Whilst clinical diagnosis has relied on signs and symptoms, the integration of clinical neurosciences is becoming more important as a means of enhancing assessment, diagnosis, and treatment. Thus, activation likelihood estimation (ALE) meta-analysis was conducted for whole-brain foci comparing implicit emotion regulation in a large sample of patients with mood and anxiety disorders and healthy controls. Twenty-four clinical studies were identified based on established criteria (e.g., DSM-5). ALE meta-analysis reported convergence of hypoactivation in patients (n = 432) in the right medial frontal gyrus (BA9), spreading to the right anterior cingulate gyrus (BA32); and in the left middle temporal gyrus (BA21), spreading to the left superior temporal gyrus (BA22). Convergence of hyperactivation was reported in patients (n = 536) in the left medial frontal gyrus (BA9), spreading to the left superior frontal gyrus and the left middle frontal gyrus. Separate analysis of the mood disorders subgroup further highlighted convergence of hyperactivation in the insula and claustrum. The implications of the current findings are discussed within the context of the Research Domain Criteria (RDoC) framework of developing diagnostic systems that are more predictive of treatment outcomes.
Description: Data availability: Raw and generated data, as well as data analysed during this review, are available within this published article and its supplementary materials.
Electronic supplementary material is available online at: https://www.nature.com/articles/s41598-025-03828-5#Sec21 .
URI: https://bura.brunel.ac.uk/handle/2438/31700
DOI: https://doi.org/10.1038/s41598-025-03828-5
Other Identifiers: ORCiD: Ben Jennings https://orcid.org/0000-0003-2472-5615
ORCiD: Survjit Cheeta https://orcid.org/0000-0002-8710-0105
Article number: 19564
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s) 2025. Rights and permissions: Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.2.65 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons